MREO Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Mereo Biopharma Group PLC - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 2.74 USD -2.49%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast MREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MREO is 5.87 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

MREO Lowest Forecast

Wall Street Target

MREO Average Forecast

Wall Street Target

MREO Highest Forecast

Wall Street Target

47% Upside

114% Upside

168% Upside

The latest public price target was made on Mar 28, 2024 by Gil Blum from Needham , who expects MREO stock to rise by 119% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Gil Blum Needham	6 USD Upside 119%	4 weeks ago Mar 28, 2024	Mereo BipPharma Group (MREO) PT Raised to $6 at Needham on increased 'launch expectations for setrusumab in OI' StreetInsider

Price Target	6 USD
Upside/Downside	119%

Y-mAbs Therapeutics Inc

49% Upside

Zealand Pharma A/S

22% Upside

Puma Biotechnology Inc

12% Downside

Turnstone Biologics Corp

380% Upside

Y-mAbs Therapeutics Inc

49% Upside

Zealand Pharma A/S

22% Upside

Puma Biotechnology Inc

12% Downside

Turnstone Biologics Corp

380% Upside

GenMont Biotech Inc

345% Upside

Kinnate Biopharma Inc

9% Downside

Mabion SA

5% Downside

Exelixis Inc

15% Upside

Revenue
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-1%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-56%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for MREO is 5.87 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

Join more than 131,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.